Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10
Published March 25, 2015 · Recall initiated: January 23, 2015
Summary
FDA records drug Class III recall D-0413-2015, published March 25, 2015 and initiated January 23, 2015. Recalling firm: Mylan Institutional LLC; Status: Terminated; Reported quantity: 78,090 vials; Lot: Lot #: UW301, UW302, Exp 02/15; UW303, UW304, UW305, UW306, Exp 04/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug and Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Institutional LLC
- Distributor
- Nationwide
- Lot
- Lot #: UW301, UW302, Exp 02/15; UW303, UW304, UW305, UW306, Exp 04/15
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAThiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) perJune 9, 2021
- FDATranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10September 9, 2020
- FDAAmiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-153-99); 10September 9, 2020
- FDADaptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: MylanAugust 12, 2020
- FDAErgoloid Mesylates ,1 mg tablets, 100 count bottle, Rx only, Manufactured by MUTUAL PHARMACEUTICAL CO., INC.,March 25, 2015
- FDAGE Healthcare Proteus XR/a with wall stand model number 2260354. Intended for use in generating radiographicMarch 18, 2015
Questions about this recall
Was Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10 recalled?
Yes. FDA published recall D-0413-2015 on March 25, 2015. Reported hazard: Subpotent Drug and Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter